Ana Kely Carvalho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Kely Carvalho has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Franco Paes Leme
Advanced Clusters in Health Technologies (NATS), Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, São Paulo, Brazil
1 shared publication - Alexis Bonfim-Melo
Frazer Institute, Faculty of Health, Medicine, and Behavioural Sciences, University of Queensland, Brisbane, Australia
1 shared publication - Bianca Ba Santos
Division of Clinical Immunology and Allergy, (LIM-60), University of São Paulo, São Paulo, Brazil
1 shared publication - Carlos Eduardo Pereira Corbett
Infectious Diseases Pathology Laboratory (LIM50), Pathology Department, Medical School, São Paulo University, São Paulo 01246-903, Brazil
1 shared publication - Esper Georges Kallas
Center of Clinical Trials and Pharmacovigilance, Instituto Butantan, São Paulo, Brazil
1 shared publication - Karina Inacio Carvalho
Hospital Israelita Albert Einstein, Instituto Israelita de Ensino e Pesquisa, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 30 March 2012
- Published by Springer Nature in Parasites & Vectors
- Vol. 5 (1) , 64
Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation
Leishmania (Viannia) shawi parasite was first characterized in 1989. Recently the protective effects of soluble leishmanial antigen (SLA) from L. (V.) shawi promastigotes were demonstrated using BALB/c mice, the susceptibility model for this parasite. In order to identify protective fractions, SLA was fractionated by reverse phase HPLC and five antigenic fractions were obtained.
- 30 March 2012
- Published by Springer Nature in Parasites & Vectors
- Vol. 5 (1) , 64
Open AccessProteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation
Leishmania (Viannia) shawi parasite was first characterized in 1989. Recently the protective effects of soluble leishmanial antigen (SLA) from L. (V.) shawi promastigotes were demonstrated using BALB/c mice, the susceptibility model for this parasite. In order to identify protective fractions, SLA was fractionated by reverse phase HPLC and five antigenic fractions were obtained.